Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Scopus BioPharma Inc. SCPS

Full chart Compare
Set alert

Price alert · SCPS

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0004 Day range 0.0004
0.0001 52-week range 0.01
YTD
0.00%
1 year
+33.33%

Financial health

Altman Z-Score

-250.87 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2017: 0.0×FY 2018: -129×FY 2019: -32.9×FY 2020: -17.1×FY 2021: -1.0×FY 2022: -0.2×
FY 2017 5y median -17.1× FY 2022
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
P/B -0.3×
FY 2017: 0.0×FY 2018: -16646×FY 2019: -1070×FY 2020: -108×FY 2021: 7.0×FY 2022: -0.3×
FY 2017 5y median -108× FY 2022
P/FCF -0.3×
FY 2017: 0.0×FY 2018: -119×FY 2019: -41.7×FY 2020: -78.5×FY 2021: -2.5×FY 2022: -0.3×
FY 2017 5y median -41.7× FY 2022
EV/EBITDA -0.2×
FY 2017: 0.0×FY 2018: -129×FY 2019: -33.0×FY 2020: -19.6×FY 2021: -0.8×FY 2022: -0.2×
FY 2017 5y median -19.6× FY 2022
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
FCF Yield -393.2%
FY 2017: 0.0%FY 2018: -0.8%FY 2019: -2.4%FY 2020: -1.3%FY 2021: -40.4%FY 2022: -393.2%
FY 2017 5y median -2.4% FY 2022

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
ROE 176.9%
FY 2017: 0.0%FY 2018: 12879.5%FY 2019: 3246.4%FY 2020: 631.7%FY 2021: -690.2%FY 2022: 176.9%
FY 2017 5y median 631.7% FY 2022
ROIC 164.4%
FY 2017: 0.0%FY 2018: 12879.5%FY 2019: 3246.4%FY 2020: -2244.4%FY 2021: -687.9%FY 2022: 164.4%
FY 2017 5y median 164.4% FY 2022
ROA -2959.7%
FY 2017: 0.0%FY 2018: -517.2%FY 2019: -348.6%FY 2020: -586.0%FY 2021: -338.7%FY 2022: -2959.7%
FY 2017 5y median -517.2% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 FY 2022
Operating Income 57.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -292.1%FY 2020: -277.5%FY 2021: -172.1%FY 2022: 57.6%
FY 2017 FY 2022
EPS (diluted) 65.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -293.0%FY 2020: -383.3%FY 2021: -85.1%FY 2022: 65.8%
FY 2017 FY 2022
Free Cash Flow 28.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -184.3%FY 2020: -18.9%FY 2021: -352.5%FY 2022: 28.9%
FY 2017 FY 2022

Financial Health

Current Ratio 0.1×
FY 2017: 1.9×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.5×FY 2021: 2.0×FY 2022: 0.1×
FY 2017 5y median 0.9× FY 2022
Quick Ratio 0.1×
FY 2017: 1.9×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.5×FY 2021: 2.0×FY 2022: 0.1×
FY 2017 5y median 0.9× FY 2022
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -1.2×FY 2021: 0.0×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
Net Debt / EBITDA 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: 0.3×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -14.4×FY 2021: -35.7×FY 2022: 0.0×
FY 2017 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2017 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31